Ana B. Argibay
Vigo, GA, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Impact of belimumab on the utility of serological markers for assessing systemic lupus erythematosus activity.
Journal: Lupus science & medicine
Published: January 22, 2026
Serum Proteomic Markers in Patients with Systemic Sclerosis in Relation to Silica Exposure.
Journal: Journal of clinical medicine
Published: February 24, 2025
Efficacy and Safety of Anakinra Plus Standard of Care for Patients With Severe COVID-19: A Randomized Phase 2/3 Clinical Trial.
Journal: JAMA network open
Published: April 07, 2023
Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension.
Journal: Scientific reports
Published: July 28, 2022
Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE).
Journal: Autoimmunity reviews
Published: July 27, 2022
Left ventricular diastolic dysfunction in systemic sclerosis: Clinical, immunological and survival differences in the Spanish RESCLE registry.
Journal: Seminars in arthritis and rheumatism
Published: March 07, 2022
The incidence rate of pulmonary arterial hypertension and scleroderma renal crisis in systemic sclerosis patients with digital ulcers on endothelin antagonist receptors (ERAs) and phosphodiesterase-5 inhibitors (PDE5i).
Journal: Rheumatology (Oxford, England)
Published: March 07, 2020
Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation.
Journal: Autoimmunity reviews
Published: December 12, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026